A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy

Clinical trial NCT04666610 · COMPLETED

Trial details

NCT number: NCT04666610
Sponsor: UCB Biopharma SRL
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Childhood Absence Epilepsy Juvenile Absence Epilepsy

Start date: 2021-07-29
Primary completion: 2026-07-07
Enrollment: 153

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.